US bans European bovine material in devices
This article was originally published in Clinica
US medical devices cannot be made from bovine material originating in western Europe because of the threat of bovine spongiform encephalopathy (BSE), says a new FDA guidance on medical devices containing materials derived from animal sources. In addition, materials from Oman, Albania, Bosnia-Herzegovina, Bulgaria, Croatia, the Czech and Slovak Republics, Hungary, Poland, Romania and Slovenia are also banned.
You may also be interested in...
Sandoz announced more than a year ago that its GP2411 biosimilar denosumab candidate had entered the clinic. Management provided an update on its progress at the recent Virtual Meet Novartis Management Investor Event.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.